Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William U Shipley

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
Journal of Medical Imaging and Radiation Oncology|February 21, 2012
Thoughtful, practical and timely radiation therapy guidelines for patients with muscle-invasive bladder cancerWilliam U Shipley
Nature Clinical Practice. Urology|January 11, 2007
Radiation-sensitizing chemotherapy after transurethral resection as an alternative treatment for high-risk T1 bladder cancerWilliam U Shipley
International Journal of Radiation Oncology, Biology, Physics|August 18, 2017
Less Is MoreWilliam U Shipley
European Urology|December 11, 2012
Words of wisdom. Re: Radiotherapy with or without chemotherapy in muscle-invasive bladder cancerJason A Efstathiou, William U Shipley
The New England Journal of Medicine|April 20, 2012
Old drugs, new purpose--bladder cancer turning a cornerWilliam U Shipley, Anthony L Zietman
Asian Journal of Andrology|December 27, 2011
The importance of combined radiation and endocrine therapy in locally advanced prostate cancerPhillip J Gray, William U Shipley
Nature Reviews. Clinical Oncology|November 21, 2012
Urological cancer. The benefits of intermittent androgen-deprivation therapyTimur Mitin, Jason A Efstathiou, William U Shipley
The New England Journal of Medicine|January 14, 2003
Prostatectomy or watchful waiting in prostate cancerJohn J Coen, Anthony L Zietman, William U Shipley
International Journal of Radiation Oncology, Biology, Physics|June 7, 2005
PSA bounces after neoadjuvant androgen deprivation and external beam radiation: impact on definitions of failureAnthony L Zietman, John P Christodouleas, William U Shipley
Asian Journal of Andrology|February 26, 2013
The opportunity cost of androgen suppression in locally advanced prostate cancerPhillip J Gray, Jason A Efstathiou, William U Shipley
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
Journal of Medical Imaging and Radiation Oncology|February 21, 2012
Thoughtful, practical and timely radiation therapy guidelines for patients with muscle-invasive bladder cancerWilliam U Shipley
Nature Clinical Practice. Urology|January 11, 2007
Radiation-sensitizing chemotherapy after transurethral resection as an alternative treatment for high-risk T1 bladder cancerWilliam U Shipley
International Journal of Radiation Oncology, Biology, Physics|August 18, 2017
Less Is MoreWilliam U Shipley
European Urology|December 11, 2012
Words of wisdom. Re: Radiotherapy with or without chemotherapy in muscle-invasive bladder cancerJason A Efstathiou, William U Shipley
The New England Journal of Medicine|April 20, 2012
Old drugs, new purpose--bladder cancer turning a cornerWilliam U Shipley, Anthony L Zietman
Asian Journal of Andrology|December 27, 2011
The importance of combined radiation and endocrine therapy in locally advanced prostate cancerPhillip J Gray, William U Shipley
Nature Reviews. Clinical Oncology|November 21, 2012
Urological cancer. The benefits of intermittent androgen-deprivation therapyTimur Mitin, Jason A Efstathiou, William U Shipley
The New England Journal of Medicine|January 14, 2003
Prostatectomy or watchful waiting in prostate cancerJohn J Coen, Anthony L Zietman, William U Shipley
International Journal of Radiation Oncology, Biology, Physics|June 7, 2005
PSA bounces after neoadjuvant androgen deprivation and external beam radiation: impact on definitions of failureAnthony L Zietman, John P Christodouleas, William U Shipley
Asian Journal of Andrology|February 26, 2013
The opportunity cost of androgen suppression in locally advanced prostate cancerPhillip J Gray, Jason A Efstathiou, William U Shipley
Pageof 14